Brief: Arca Biopharma Announces Submission Of Ind Application To U.S. FDA For Ab201 As A Potential Treatment For Covid-19

Oruka Therapeutics

21/09/2020 13:34

Sept 21 (Reuters) - ARCA Biopharma Inc  ABIO.O :
    * ARCA BIOPHARMA ANNOUNCES SUBMISSION OF IND APPLICATION TO
U.S.
FDA FOR AB201 AS A POTENTIAL TREATMENT FOR COVID-19
    * ARCA BIOPHARMA - PENDING FDA FEEDBACK, ANTICIPATES
INITIATING
PHASE 2B PORTION OF SEQUENTIAL PHASE 2B/3 CLINICAL EVALUATION OF
AB201 AS EARLY AS Q4 OF THIS YEAR

Source text for Eikon:  ID:nGNX7RMNSB 
Further company coverage:  ABIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))